Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study

被引：0
|
作者：
Easton, Rachael [1 ]
Tremper, Louise [2 ]
Shear, Charles [1 ]
机构：
[1] CSL Behring, King Of Prussia, PA USA
[2] CSL Ltd, Clin Study Management, Parkville, Vic, Australia
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Acute coronary syndromes; Apolipoproteins; HDL elevating therapies; Pharmacokinetics; Clinical trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11892
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CSL112, a Novel Formulation of Human Apolipoprotein A-I, Provides Sustained Increases in Biomarkers of Cholesterol Transport Following Repeat Dosing: A Placebo-Controlled, Randomized Multiple Ascending Dose Study in Healthy Subjects
    Gille, Andreas
    Easton, Rachael
    Wright, Samuel
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [2] CSL112, a Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Healthy Subjects: A, Placebo-Controlled, Double-Blinded, Randomized Single Ascending Dose Study
    Gille, Andreas
    Easton, Rachael
    Wright, Samuel
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [3] CSL112, A Novel Formulation of Human Apolipoprotein A-I, Dramatically Increases Cholesterol Efflux Capacity in Patients With Stable Atherothrombotic Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study
    Gille, Andreas
    D'Andrea, Denise
    Easton, Rachel
    Tricoci, Pierluigi
    Alexander, John H.
    Wright, Samuel D.
    Shear, Charles L.
    CIRCULATION, 2013, 128 (22)
  • [4] Infusion of CSL112, a novel formulation of human apolipoprotein A-I, in healthy subjects removes tissue cholesterol and directs its clearance
    Gille, A.
    Wright, S.
    Easton, R.
    Shear, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 350 - 350
  • [5] A Multiple Ascending Dose Study of CSL112, an Infused Formulation of ApoA-I
    Easton, Rachael
    Gille, Andreas
    D'Andrea, Denise
    Davis, Roslyn
    Wright, Samuel D.
    Shear, Charles
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (03): : 301 - 310
  • [6] Evaluation of Potential Antiplatelet Effects of CSL112, a Novel Formulation of Human Apolipoprotein A-I: Results From a Phase 2a Study
    Gurbel, Paul A.
    Bliden, Kevin P.
    D'Andrea, Denise M.
    Henderson, Karen W.
    Alexander, John H.
    Tantry, Udaya S.
    Shear, Charles
    Tricoci, Pierluigi
    CIRCULATION, 2013, 128 (22)
  • [7] Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
    Tortorici, Michael A.
    Duffy, Danielle
    Evans, Rebecca
    Feaster, John
    Gille, Andreas
    Mant, Timothy G. K.
    Wright, Samuel D.
    D'Andrea, Denise
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (05): : 628 - 636
  • [8] The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
    Gibson, C. Michael
    Kerneis, Mathieu
    Yee, Megan K.
    Daaboul, Yazan
    Korjian, Serge
    Mehr, Ali Poyan
    Tricoci, Pierluigi
    Alexander, John H.
    Kastelein, John J. P.
    Mehran, Roxana
    Bode, Christoph
    Lewis, Basil S.
    Mehta, Ravindra
    Duffy, Danielle
    Feaster, John
    Halabi, Majdi
    Angiolillo, Dominick J.
    Duerschmied, Daniel
    Ophuis, Ton Oude
    Merkely, Bela
    AMERICAN HEART JOURNAL, 2019, 208 : 81 - 90
  • [9] Safety and Tolerability of CSL112 in Subjects With Stable Atherothrombotic Disease: Results From a Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending-Dose Study
    Tricoci, Pierluigi
    D'Andrea, Denise M.
    Gurbel, Paul
    Cuchel, Marina
    Winstons, Brion
    Schott, Robert
    Weiss, Robert
    Blazing, Michael
    Corteville, David
    Bailey, Alison
    Angiolillo, Dominick J.
    Dalitz, Penelope
    Myles-Di Mauro, Shelley
    Shear, Charles
    Alexander, John H.
    CIRCULATION, 2013, 128 (22)
  • [10] A Novel Nonradioactive Method Documents Strong Elevation of the Cholesterol Esterification Rate by CSL112, a Novel Formulation of Human Apolipoprotein A-I
    Boerema, David J.
    Martin, Kirstee L.
    Meikle, Peter J.
    Wright, Samuel D.
    Gille, Andreas
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
12345